310,124 Shares in Envista Holdings Co. (NYSE:NVST) Bought by Trexquant Investment LP

Trexquant Investment LP bought a new stake in Envista Holdings Co. (NYSE:NVST) during the 4th quarter, Holdings Channel.com reports. The institutional investor bought 310,124 shares of the company’s stock, valued at approximately $5,982,000.

Other hedge funds have also made changes to their positions in the company. Venturi Wealth Management LLC increased its holdings in Envista by 528.4% during the 4th quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company’s stock valued at $38,000 after acquiring an additional 1,638 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Envista by 30.5% in the fourth quarter. GAMMA Investing LLC now owns 2,304 shares of the company’s stock valued at $44,000 after purchasing an additional 538 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of Envista during the 4th quarter worth approximately $53,000. Mitsubishi UFJ Trust & Banking Corp acquired a new position in shares of Envista during the 4th quarter worth approximately $86,000. Finally, KBC Group NV lifted its stake in Envista by 63.9% in the 4th quarter. KBC Group NV now owns 7,903 shares of the company’s stock valued at $152,000 after buying an additional 3,082 shares in the last quarter.

Envista Price Performance

Shares of Envista stock opened at $15.47 on Friday. The stock has a market capitalization of $2.66 billion, a P/E ratio of -2.38, a PEG ratio of 1.27 and a beta of 1.12. The company has a current ratio of 2.04, a quick ratio of 1.76 and a debt-to-equity ratio of 0.44. The business’s fifty day moving average price is $19.18 and its 200 day moving average price is $19.52. Envista Holdings Co. has a twelve month low of $14.77 and a twelve month high of $23.00.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. As a group, research analysts anticipate that Envista Holdings Co. will post 1 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on NVST shares. New Street Research set a $19.00 price target on Envista in a report on Thursday, March 6th. JPMorgan Chase & Co. reduced their target price on shares of Envista from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Thursday, March 6th. Morgan Stanley lowered their price target on shares of Envista from $20.00 to $19.00 and set an “equal weight” rating for the company in a report on Thursday, March 6th. Wells Fargo & Company set a $19.00 price objective on shares of Envista in a research note on Saturday, March 8th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a research note on Thursday, March 6th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, Envista currently has a consensus rating of “Hold” and a consensus price target of $20.18.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.